Table 1 Baseline characteristics by study arm
From: Single-dose azithromycin for child growth in Burkina Faso: a randomized controlled trial
Characteristic | Azithromycin (N = 230) | Placebo (N = 220) |
|---|---|---|
Age, months (median, IQR) | 26 (15 to 39) | 26 (17 to 38) |
Female sex | 53.1% | 48.4% |
Child is breastfeeding | 40.4% | 35.6% |
Mother’s age (median, IQR) | 26.5 (23 to 32) | 27 (23 to 33) |
Mother’s education | ||
 None | 52.2% | 55.3% |
 Primary | 26.5% | 25.6% |
 Secondary or higher | 21.3% | 19.2% |
Mid-upper arm circumference, cm (median, IQR) | 14 (13 to 15) | 14.3 (13.5 to 15) |
Weight, kg (median, IQR) | 10.9 (8.8 to 13.6) | 11.4 (9.4 to 13.4) |
Height, cm (median, IQR) | 84.7 (74.8 to 95.0) | 85.8 (77.3 to 93.5) |
Weight-for-height Z-score (mean, SD) | −0.6 (1.2) | −0.4 (1.1) |
Height-for-age Z-score (mean, SD) | −1.1 (1.2) | −0.9 (1.3) |
Weight-for-age Z-score (mean, SD) | −1.0 (1.1) | −0.7 (1.1) |
Wasted (WHZ < -2), N (%) | 10.5% | 5.9% |
Stunted (HAZ < -2), N (%) | 16.7% | 13.2% |
Underweight (WAZ < -2), N (%) | 18.0% | 9.1% |
Mid-upper arm circumference < 12.5 cm | 4.8% | 3.2% |
Malaria RDT Positivea | 6.1% | 3.6% |